These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25686498)

  • 1. Rab25 upregulation correlates with the proliferation, migration, and invasion of renal cell carcinoma.
    Li Y; Jia Q; Zhang Q; Wan Y
    Biochem Biophys Res Commun; 2015 Mar; 458(4):745-50. PubMed ID: 25686498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7.
    Su B; Zhao W; Shi B; Zhang Z; Yu X; Xie F; Guo Z; Zhang X; Liu J; Shen Q; Wang J; Li X; Zhang Z; Zhou L
    Mol Cancer; 2014 Sep; 13():206. PubMed ID: 25193015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
    Wang H; Chen B; Duan B; Zheng J; Wu X
    Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rab25 regulates invasion and metastasis in head and neck cancer.
    Amornphimoltham P; Rechache K; Thompson J; Masedunskas A; Leelahavanichkul K; Patel V; Molinolo A; Gutkind JS; Weigert R
    Clin Cancer Res; 2013 Mar; 19(6):1375-88. PubMed ID: 23340300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA‑212 inhibits the proliferation and invasion of human renal cell carcinoma by targeting FOXA1.
    Tong Z; Meng X; Wang J; Wang L
    Mol Med Rep; 2018 Jan; 17(1):1361-1367. PubMed ID: 29115609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
    Wu D; Pan H; Zhou Y; Zhou J; Fan Y; Qu P
    Mol Med Rep; 2014 Jun; 9(6):2491-8. PubMed ID: 24714873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-204 inhibits the proliferation and invasion of renal cell carcinoma by inhibiting RAB22A expression.
    Xiong F; Liu K; Zhang F; Sha K; Wang X; Guo X; Huang N
    Oncol Rep; 2016 May; 35(5):3000-8. PubMed ID: 26883716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-22 is downregulated in clear cell renal cell carcinoma, and inhibits cell growth, migration and invasion by targeting PTEN.
    Fan W; Huang J; Xiao H; Liang Z
    Mol Med Rep; 2016 Jun; 13(6):4800-6. PubMed ID: 27082730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer.
    Shahabi A; Naghili B; Ansarin K; Montazeri M; Dadashpour M; Zarghami N
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):305-313. PubMed ID: 33507713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
    Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X
    Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25.
    Feng ZH; Fang Y; Zhao LY; Lu J; Wang YQ; Chen ZH; Huang Y; Wei JH; Liang YP; Cen JJ; Pan YH; Liao B; Chen W; Luo JH
    Cancer Sci; 2017 Aug; 108(8):1620-1627. PubMed ID: 28612496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
    Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
    Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
    Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
    Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
    J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COP1 is downregulated in renal cell carcinoma (RCC) and inhibits the migration of RCC ACHN cells in vitro.
    Ta L; Xuan C; Xing N; Zhu X
    Mol Med Rep; 2016 Aug; 14(2):1371-8. PubMed ID: 27278120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of miR‑130b as an oncogene in renal cell carcinoma.
    Li Y; Chen D; Li Y; Jin L; Liu J; Su Z; Qi Z; Shi M; Jiang Z; Gui Y; Yang S; Mao X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1902-8. PubMed ID: 26717956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
    Pan X; Li Z; Zhao L; Quan J; Zhou L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y
    Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
    Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
    Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RCCRT1 is correlated with prognosis and promotes cell migration and invasion in renal cell carcinoma.
    Song S; Wu Z; Wang C; Liu B; Ye X; Chen J; Yang Q; Ye H; Xu B; Wang L
    Urology; 2014 Sep; 84(3):730.e1-7. PubMed ID: 25168566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.